WIRE)–Flexible Stenting Solutions, Inc. (FSS), a leading developer of next
generation peripheral arterial, venous, neurovascular and biliary stents,
announced today the successful implantation of its 200 mm FlexStent®
Femoropopliteal Self Expanding Stent System by Dr. Andrew Holden at Auckland
City Hospital in New Zealand. With the addition of the 200 mm length FlexStent®
Femoropopliteal Self Expanding Stent System under CE Mark (Conformite
Europeene), stent sizes now include a complete matrix of 5, 6, 7 and 8 mm
diameters with lengths ranging from 30 to 200 mm in a 6 French delivery system.
Dr. Andrew Holden, Associate Professor and Director of
Interventional Radiology at Auckland
had conducted FSS first-in-man study of the FlexStent® in 2009. In yesterdays
procedure, he implanted a 6 mm diameter x 200 mm long FlexStent® followed by
overlapping a 6×150 mm and a 6×40 mm stents to treat a long, diffuse lesion in
the patients femoropopliteal artery. Dr. Holden commented, “The 200 mm
FlexStent® was able to be deployed across the aortic bifurcation in the
contralateral SFA easily and accurately with an excellent imaging and clinical
During the procedure, Dr. Holden was accompanied by Bradley
Beach, FSS VP of R&D and co-inventor of the FlexStent® technology. Mr.
Beach added, “I was thrilled to see the confidence in which Dr. Holden used our
devices for this procedure. His feedback in the 2009 first-in-man trial was
instrumental in our designing the current low-deployment force system.”
Dr. Holden is scheduled to transmit a live case using the
FlexStent® at the TCT Conference in San
Francisco on Wednesday, November 9, 2011.
About Flexible Stenting Solutions Inc.
Flexible Stenting Solutions Inc. (FSS) is a leading developer of
third-generation flexible peripheral arterial,
venous, neurovascular and biliary stents. Its fully connected stent
has coupled technology with clinical needs by providing an atraumatic, highly
durable and fatigue resistant stent with superior radial stiffness, flexibility
and conformability. FSS is an ISO 13485:2003 certified company and has received
regulatory approvals on several products. FSS clinical trials in the US and Japan are underway.
For further information on Flexible Stenting Solutions,
please visit the company website at www.flexiblestent.com.